Log in to save to my catalogue

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free...

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727296

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

About this item

Full title

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2022-01, Vol.36 (1), p.271-274

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727296

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8727296

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-021-01322-1

How to access this item